Aleksa Popovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksa Popovic has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ana Andrijevic
Clinic for Anesthesiology and Intensive Care, Institute for Cardiovascular Disease, 11030 Belgrade, Serbia
1 shared publication - Irina Nenadic
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Maja Stojanovic
Clinic for Anesthesiology and Intensive Care, Institute for Cardiovascular Disease, 11030 Belgrade, Serbia
1 shared publication - Marko Djuric
Clinic for Anesthesiology and Intensive Care, University Clinical Hospital Center “Dr Dragisa Misovic—Dedinje”, 11000 Belgrade, Serbia
1 shared publication - Slobodan Pesic
Vascular Surgery Clinic, Institute for Cardiovascular Diseases “Dedinje”, Belgrade, Serbia
1 shared publication - Suzana Bojic
Faculty of Medicine, University of Belgrade
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 31 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 433
Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.
- 31 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 433
Top Cited PapersOpen AccessVascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.